Literature DB >> 1649926

Cytomegalovirus epididymitis following renal transplantation.

J M McCarthy1, M G McLoughlin, C R Shackleton, E C Cameron, C K Yeung, E C Jones, P A Keown.   

Abstract

Cytomegalovirus infection is an important cause of morbidity and mortality in immunocompromised individuals. The disease is usually systemic in expression although localized infection can occur, particularly in the lung, liver, retina and gastrointestinal tract. We report a case of cytomegalovirus epididymitis with limited systemic manifestations occurring 2 months after renal transplantation in a patient immunosuppressed with azathioprine, prednisone and cyclosporine. Diagnosis was confirmed by observation of typical cytopathic changes in epididymal cells. Clinical resolution occurred with epididymo-orchiectomy and 9-(1,3-dihydroxy-2-proproxymethyl)guanine therapy. To our knowledge this presentation has not been described previously in the transplant literature and it is extremely rare in other forms of inherited or acquired immune deficiency.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649926     DOI: 10.1016/s0022-5347(17)37811-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

Review 1.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 2.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

3.  Candida albicans epididymo-orchitis and fungemia in a patient with chronic myelogenous leukemia.

Authors:  M Pimentel; L E Nicolle; S Qureshi
Journal:  Can J Infect Dis       Date:  1996-09

Review 4.  Cytomegalovirus prostatitis. Case report and review of the literature.

Authors:  T C McKay; D M Albala; K Sendelbach; P Gattuso
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.